Your browser doesn't support javascript.
loading
Efficacy of far infrared functional glasses in the treatment of meibomian gland dysfunction-related dry eye.
Tian, Lei; Guo, Yihan; Wang, Silu; Li, Zhongying; Wang, Ningli; Jie, Ying.
Afiliación
  • Tian L; Beijing Institute of Ophthalmology Beijing Tongren Eye Center Beijing Tongren Hospital Capital Medical University, Beijing Ophthalmology & Visual Sciences Key Laboratory Beijing China.
  • Guo Y; Beijing Advanced Innovation Center for Big Data-Based Precision Medicine Beihang University and Capital Medical University Beijing China.
  • Wang S; Beijing Institute of Ophthalmology Beijing Tongren Eye Center Beijing Tongren Hospital Capital Medical University, Beijing Ophthalmology & Visual Sciences Key Laboratory Beijing China.
  • Li Z; Beijing Institute of Ophthalmology Beijing Tongren Eye Center Beijing Tongren Hospital Capital Medical University, Beijing Ophthalmology & Visual Sciences Key Laboratory Beijing China.
  • Wang N; Beijing Institute of Ophthalmology Beijing Tongren Eye Center Beijing Tongren Hospital Capital Medical University, Beijing Ophthalmology & Visual Sciences Key Laboratory Beijing China.
  • Jie Y; Beijing Institute of Ophthalmology Beijing Tongren Eye Center Beijing Tongren Hospital Capital Medical University, Beijing Ophthalmology & Visual Sciences Key Laboratory Beijing China.
MedComm (2020) ; 5(4): e507, 2024 Apr.
Article en En | MEDLINE | ID: mdl-38525107
ABSTRACT
Meibomian gland dysfunction (MGD)-related dry eye disease (DED) is a significant subtype of DED. In this research, we investigate the effectiveness of far infrared (FIR) functional glasses in the treatment of MGD-related DED. According to the TFO DEWS II diagnostic criteria, 61 eyes with MGD-related DED were included. All participants wore functional FIR glasses throughout the day for a period of 4 weeks and were followed up three times during the treatment. All subjects were followed up thoroughly in accordance with the DED clinical examination procedure. Ultimately, the treatment's impact was assessed. We found the Visual Analogue Scale and Ocular Surface Disease Index scores after FIR treatment were significantly lower than the baseline values (p < 0.05). Compared with the baseline, fluorescein tear breakup time and corneal fluorescein staining score after FIR treatment were significantly improved (p < 0.05). The eyelid margin signs, meibum quality, and meibomian gland expressibility after the 4-week treatment were significantly better than those at baseline (p < 0.05). We can see that wearing the FIR functional glasses significantly relieves the symptoms and signs of patients. We believe FIR therapy could be considered as a new method of MGD-related DED.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: MedComm (2020) Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: MedComm (2020) Año: 2024 Tipo del documento: Article